Ibrance 125 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DR26F5CHS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on July 23, 2026, for IBRANCE 125 mg tablets with a ceiling value of $8,555.21 and an ultimate completion date of August 13, 2026.
The order is issued under a Defense Logistics Agency indefinite delivery contract for pharmaceutical supply to military treatment facilities and federal healthcare systems. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F5CHS?
SPE2DR26F5CHS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2026.
How much is contract SPE2DR26F5CHS worth?
The government has obligated $8,555 on SPE2DR26F5CHS.
Is contract SPE2DR26F5CHS an order under another contract?
Yes. SPE2DR26F5CHS is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F5CHS competed?
The extent of competition for SPE2DR26F5CHS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award